Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease.

Merling RK, Kuhns DB, Sweeney CL, Wu X, Burkett S, Chu J, Lee J, Koontz S, Di Pasquale G, Afione SA, Chiorini JA, Kang EM, Choi U, De Ravin SS, Malech HL.

Blood Adv. 2016 Dec 28;1(4):270-278. doi: 10.1182/bloodadvances.2016001214. eCollection 2017 Jan 10.

2.

Hepatitis Delta Virus Detected in Salivary Glands of Sjögren's Syndrome Patients and Recapitulates a Sjögren's Syndrome-Like Phenotype in Vivo.

Weller ML, Gardener MR, Bogus ZC, Smith MA, Astorri E, Michael DG, Michael DA, Zheng C, Burbelo PD, Lai Z, Wilson PA, Swaim W, Handelman B, Afione SA, Bombardieri M, Chiorini JA.

Pathog Immun. 2016 May;1(1):12-40.

3.

Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.

Smith RH, Afione SA, Kotin RM.

Biotechniques. 2002 Jul;33(1):204-6, 208, 210-1.

4.

Delayed expression of adeno-associated virus vector DNA.

Afione SA, Wang J, Walsh S, Guggino WB, Flotte TR.

Intervirology. 1999;42(4):213-20.

PMID:
10567839
5.

Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.

Kearns WG, Afione SA, Fulmer SB, Pang MC, Erikson D, Egan M, Landrum MJ, Flotte TR, Cutting GR.

Gene Ther. 1996 Sep;3(9):748-55.

PMID:
8875221
6.

Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.

Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR.

Gene Ther. 1996 Aug;3(8):658-68.

PMID:
8854091
7.

In vivo model of adeno-associated virus vector persistence and rescue.

Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR.

J Virol. 1996 May;70(5):3235-41.

8.

Gene therapy vectors as drug delivery systems.

Afione SA, Conrad CK, Flotte TR.

Clin Pharmacokinet. 1995 Mar;28(3):181-9. Review. No abstract available.

PMID:
7758249
9.

An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.

Flotte TR, Barraza-Ortiz X, Solow R, Afione SA, Carter BJ, Guggino WB.

Gene Ther. 1995 Jan;2(1):29-37.

PMID:
7712331
10.

Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration.

Flotte TR, Afione SA, Zeitlin PL.

Am J Respir Cell Mol Biol. 1994 Nov;11(5):517-21.

PMID:
7946381
11.

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ.

Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10613-7.

12.

Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.

Flotte TR, Afione SA, Solow R, Drumm ML, Markakis D, Guggino WB, Zeitlin PL, Carter BJ.

J Biol Chem. 1993 Feb 15;268(5):3781-90.

Supplemental Content

Loading ...
Support Center